Stability and Degradation-based Proteome Profiling Reveals Cannabidiol as a Promising CDC123-eIF2γ Inhibitor for Colorectal Cancer Therapy

H Hengyuan Yu (College of Pharmaceutical Sciences) Y Yang Chen M Mingfei Wu (School of Pharmacy) W Wentao Wang (College of Pharmaceutical Sciences) J Junjie Qiu R Rui Xu (College & Hospital of Stomatology) J Jie Tong (PET Center, Department of Radiology and Biomedical Imaging) Y Yong Chen X Xuesong Liu (College of Pharmaceutical Sciences) Y Yongjiang Wu (College of Pharmaceutical Sciences) P Pengfei Xu T Tao Hu J Jing Miao (Research Center for Clinical Pharmacy, College of Pharmaceutical Sciences) X Xiaowu Dong (College of Pharmaceutical Sciences) J Jinxin Che (College of Pharmaceutical Sciences) S Shuai Liu (College of Materials Science and Engineering) S Su Zeng (College of Pharmaceutical Sciences) T Tengfei Xu (Research Center for Clinical Pharmacy, College of Pharmaceutical Sciences)